Financing Cash Flow
Eli Lilly Financing Cash Flow decreased by 20.5% to -$3.47B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 351.5%, from $1.38B to -$3.47B. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -18.8% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.08B | -$463.20M | -$1.53B | -$2.88B | -$123.70M | -$1.26B | -$1.14B | $412.30M | -$1.03B | $572.00M | $3.54B | -$311.30M | $1.56B | $211.30M | $1.38B | -$1.24B | $531.00M | -$2.88B | -$3.47B |
| QoQ Change | — | +57.2% | -229.6% | -88.6% | +95.7% | -921.3% | +9.6% | +136.1% | -350.6% | +155.4% | +519.7% | -108.8% | +599.7% | -86.4% | +553.0% | -190.2% | +142.7% | -642.1% | -20.5% |
| YoY Change | — | — | — | — | +88.6% | -172.7% | +25.2% | +114.3% | -735.4% | +145.3% | +410.6% | -175.5% | +250.5% | -63.1% | +543.2% | -180.0% | +151.3% | — | -351.5% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Eli Lilly's financing cash flow?
- Eli Lilly (LLY) reported financing cash flow of -$3.47B in Q1 2026.
- How has Eli Lilly's financing cash flow changed year-over-year?
- Eli Lilly's financing cash flow decreased by 351.5% year-over-year, from $1.38B to -$3.47B.
- What is the long-term trend for Eli Lilly's financing cash flow?
- Over 3 years (2021 to 2025), Eli Lilly's financing cash flow has grown at a -18.8% compound annual growth rate (CAGR), from -$4.13B to -$2.21B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.